The Impact of Genetic Heterogeneity on Synthetic Lethality in Cancer . (360G-Wellcome-103049_Z_13_Z)
My overall goal is to understand why a synthetic lethal interaction observed in one individual may be absent in another, and to establish any rules that may be used to identify and prioritise those interactions most robust to genetic heterogeneity. My first key goal is to understand what factors might disrupt a given synthetic lethal interaction. I will assess this by using a reverse genetics approach to try to disrupt a well characterised interaction. My second key goal is to test wheth er robust synthetic lethal interactions can be identified by combining multiple screens from diverse cell lines. By focussing on the most widely screened oncogene, I will develop data integration methods that may be applicable to other mutations as the data associated with them increases. This will involve computational work followed by experimental validation. My final key goal is to find out whether certain categories of interactions, such as those between members of the same pathway, are m ore robust to changes in genetic background than others. Because experimental studies of individual genes or individual synthetic lethal interactions preclude the assessment of such trends, I will use computational modelling to assess a large number of synthetic lethal interactions across diverse backgrounds.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 125000 |
Applicant Surname | Ryan |
Approval Committee | Basic Science Interview Committee |
Award Date | 2013-11-13T00:00:00+00:00 |
Financial Year | 2013/14 |
Grant Programme: Title | Sir Henry Wellcome Postdoctoral Fellowship |
Internal ID | 103049/Z/13/Z |
Lead Applicant | Dr Colm Ryan |
Partnership Name | SFI-HRB-Wellcome Trust partnership |
Partnership Value | 250000 |
Planned Dates: End Date | 2017-07-23T00:00:00+00:00 |
Planned Dates: Start Date | 2014-07-01T00:00:00+00:00 |
Recipient Org: Country | Ireland |
Region | Ireland |
Sponsor(s) | Prof Walter Kolch |